Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas
Compose a Response to This Article
Other responses
No responses have been published for this article.
